24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
specialties & services
Dr. Noel Estopinal is a radiation oncologist from Alabama, Huntsville who got his medical degree from Louisiana State University School of Medicine. He is associated with many hospitals around the area, including Decatur General Hospital and Crestwood Medical Center. After he had got his medical diploma, he continued with an internship at the Medical Center of Louisiana –Tulane. Finally, he completed his studies with a residency at the University of Texas Medical Branch Hospitals in radiation oncology.
Louisiana State University
Medical School
Medical Center of Louisiana - Tulane
Internship
University of Texas Medical Branch Hospitals
Residency
American Board of Internal Medicine - Oncology
Athens Limestone Hospital
Languages: English/Spanish
(256) 233-9292
700 Market St W
Athens, Alabama 35611 
Crestwood Medical Center
Languages: English/Spanish
(256) 429-4000
1 Hospital Drive Southwest
Huntsville, Alabama 35801
Decatur Morgan Hospital
Languages: English/Spanish
(256) 341-2000
1201 7th St SE
Decatur, Alabama 35601
Hill Hospital of Sumter County
Languages: English/Spanish
(205) 392-5263
751 Derby Dr
York, Alabama 36925
Huntsville Hospital
Languages: English/Spanish
(256) 265–1000
101 Sivley Rd SW
Huntsville, Alabama 35801
A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer.
Anné, P. R., Machtay, M., Rosenthal, D. I., Brizel, D. M., Morrison, W. H., Irwin, D. H., Chougule, P. B., Estopinal, N. C., Berson, A., Curran, W. J.; Int J Radiat Oncol Biol Phys. 2007 Feb 1.
See more >>
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer.
Ring, B.Z., Seitz, R.S., Beck, R., Shasteen, W.J., Tarr, S.M., Cheang, M.U., Yoder, B.J., Budd, G.T., Nielsen, T.O., Hicks, D.G., Estopinal, N.C., Ross, D.T.; J Clin Oncol. 2006 Jul 1.
See more >>
The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk o...
Hicks, D. G., Janarthanan, B. R., Vardarajan, R., Kulkarni, S. A., Khoury, T., Dim, D., Budd, G. T., Yoder, B. J., Tubbs, R., Schreeder, M. T., Estopinal, N. C., Beck,...; BMC Cancer. 2010.
See more >>
Hospitals & Clinics
